Immune evasion by human cytomegalovirus: Lessons in immunology and cell biology

Seminars in Immunology

Volumn 13, Issue 1, 2001, Pages 41-49

  Loenen, Wil A M ^a   Bruggeman, C A ^a   Wiertz, E J H J ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytomegalovirus; Immune evasion; MHC class I homologue; US2 family

Indexed keywords

CHEMOKINE RECEPTOR; FC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR RECEPTOR;

CYTOMEGALOVIRUS INFECTION; HOST RESISTANCE; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOMODULATION; NATURAL KILLER CELL; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS GENE;

EID: 0035054048     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.2001.0294     Document Type: Article

References (51)

1. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens
2. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells
3. Human CMV, MHC class I and inhibitory signalling receptors: More questions than answers
4. Natural killer cell activation and inhibition by receptors for MHC class I
5. The inhibitory receptor LIR-1 uses a common binding interaction to recognize MHC class I molecules and the viral homolog UL18
6. The r144 major histocompatibility complex class I-like gene of rat cytomegalovirus is dispensable for both acute and long-term infection in the immunocompromised host
7. Cytomegalovirus evasion of natural killer cell responses
8. Modulating chemokines: More lessons from viruses
9. Deletion of the R78 G protein-coupled receptor gene from rat cytomegalovirus results in an attenuated, syncytium-inducing mutant strain
10. The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection
11. Molecular mimicry by cytomegaloviruses. Function of cytomegalovirus-encoded homologues of G protein-coupled receptors, MHC class I heavy chains and chemokines
12. Primate cytomegaloviruses encode and express an IL-10-like protein
13. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169
14. Cytomegalovirus encodes a potent alpha chemokine
15. Cutting edge: A novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus
16. Tumor necrosis factor receptor family members in the immune system
17. CD27 and (TNFR) relatives in the immune system: Their role in health and disease
18. Demonstration of immunoglobulin G receptors induced by human cytomegalovirus
19. Degradation of cell proteins and the generation of MHC class I-presented peptides
20. Sec61-mediated transfer of a membrane protein front the endoplasmic reticulum to the proteasome for destruction
21. Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potential
22. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome
23. The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products
24. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains
25. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules
26. The functionality of HLA-G is emerging
27. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11
28. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
29. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly
30. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter
31. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol
32. A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cells
33. The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains
34. The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate
35. CD40-CD40ligand interactions and their role in cytotoxic T lymphocyte priming and anti-timor immunity
36. CD40 and its crucial role as a member of the TNFR family
37. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells
38. Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression
39. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway
40. Human cytomegalovirus infection downregulates expression of the cellular aminopeptidases CD10 and CD13
41. Functions of nonclassical MHC and non-MHC-encoded class I molecules
42. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40
43. Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CDS7+CD28- CD8+ T-cell population
44. Recall response to cytomegalovirus in allograft recipients: Mobilization of CD57+, CD28+ cells before expansion of CD57+, CD28- cells within the CD8+ T lymphocyte compartment
45. CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: Expansion of an uncommon CD8+ CD57- subset and its progressive replacement by CD8+ CD57+ T cells
46. Distribution of human CMV-specific memory T cells among the CD8pos, subsets defined by CD57, CD27, and CD45 isoforms
47. Phenotypic and functional separation of memory and effector human CD8+ T cells
48. Control of lymphocyte function through CD27-CD70 interactions
49. Deconstructing membrane traffic